The therapeutic relevance of microRNA-199b in preclinical models of heart failure by Duygu, Burcu
  
 
The therapeutic relevance of microRNA-199b in
preclinical models of heart failure
Citation for published version (APA):
Duygu, B. (2017). The therapeutic relevance of microRNA-199b in preclinical models of heart failure.
Maastricht: Maastricht University. https://doi.org/10.26481/dis.20171027bud
Document status and date:
Published: 01/01/2017
DOI:
10.26481/dis.20171027bud
Document Version:
Publisher's PDF, also known as Version of record
Please check the document version of this publication:
• A submitted manuscript is the version of the article upon submission and before peer-review. There can
be important differences between the submitted version and the official published version of record.
People interested in the research are advised to contact the author for the final version of the publication,
or visit the DOI to the publisher's website.
• The final author version and the galley proof are versions of the publication after peer review.
• The final published version features the final layout of the paper including the volume, issue and page
numbers.
Link to publication
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these
rights.
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
• You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal.
If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above,
please follow below link for the End User Agreement:
www.umlib.nl/taverne-license
Take down policy
If you believe that this document breaches copyright please contact us at:
repository@maastrichtuniversity.nl
providing details and we will investigate your claim.
Download date: 04 Dec. 2019
Propositions belonging to this thesis 
 
The therapeutic relevance of microRNA-199b in preclinical 
models of heart failure  
 
Burcu Duygu 
2017 
 
 
1. Cardiac injury by ischemia and/or pressure overload triggers the 
upregulation of miR-199b. (this thesis) 
2. miR-199b is proven in different preclinical models of heart failure to be a 
valuable therapeutic target by means of its critical roles in key regulatory 
pathways. (this thesis) 
3. Among the tested anti-miR-199b oligonucleotides, antagomir designed 
with a cholesterol moiety at the 5’ end accomplished the most efficient 
downregulation of miR-199b in the heart. (this thesis)   
4. Comprehensive studies into the distinct subtypes of heart failure are 
required to determine therapeutic significance of a molecule before 
extrapolating preclinical data to clinical application. (this thesis, 
valorization) 
5. ‘Despite advances in care, we found that men and women with a 
diagnosis of HF continue to have worse survival than patients with one of 
several common cancers.’ (M.A. Mamas Eur J Heart Fail 2017)  
6. ‘Remarkably, there is a direct correlation between the number of miRNAs 
and morphological complexity, suggesting that miRNA innovation may be 
a key player in the emergence of increasingly complex organisms.’       
(E. Berezikov Nat Rev Genet 2010)  
7. Intelligence without ambition is a bird without wings. (Salvador Dali) 
8. It does not matter how slowly you go as long as you do not stop. 
(Anonymous)   
 
